Fmoc-O-tert.butyl-L-threonine

Fmoc-O-tert.butyl-L-threonine is an Fmoc-protected L-threonine derivative in which the side-chain hydroxyl is masked as an O-tert-butyl ether, preserving the threonine stereocenter while providing orthogonal protection for peptide synthesis. The molecule contains an Fmoc carbamate on the amino functionality and a tert-butyl-protected alcohol on the side chain, creating a stable, non-zwitterionic building block that can be handled as a solid while remaining compatible with standard coupling chemistries. The protected alcohol and carbamate reduce undesired side reactions during assembly, while the chiral center and β-hydroxy side chain geometry support downstream functionalization after deprotection. The combination of orthogonal protecting groups makes this compound a practical amino acid ester-free peptide building block and a chiral intermediate for generating threonine-derived motifs in synthetic and biochemical workflows.

1. Peptide Synthesis

Fmoc-O-tert.butyl-L-threonine is used in solid-phase peptide synthesis where the Fmoc group enables stepwise N-terminal deprotection and the O-tert-butyl ether prevents side-chain hydroxyl participation during chain elongation. The threonine backbone provides the canonical amino acid coupling handle, while the protected β-hydroxy side chain maintains chemoselectivity against acylation and oxidative side reactions under typical peptide assembly conditions. After peptide assembly, tert-butyl removal can reveal the native threonine hydroxyl for subsequent derivatization, phosphorylation-mimetic chemistry, or conjugation-site generation. The resulting threonine-containing peptides and peptide fragments support structure-activity relationship studies and peptide library construction requiring controlled side-chain functionality.

2. Side-Chain Functionalization

Fmoc-O-tert.butyl-L-threonine is applied as a chiral amino acid intermediate for side-chain modification strategies that target the threonine β-hydroxyl group while maintaining an Fmoc-protected amine during early synthetic steps. The O-tert-butyl ether provides a removable handle that can be converted into alcohol-reactive derivatives such as activated esters, carbonate-based linkers, or protected hydroxyl forms for orthogonal coupling. The retained stereochemistry at the threonine center supports stereodefined β-hydroxy substitution patterns used in peptidomimetic construction and scaffold diversification. Downstream transformations can generate threonine analogs for chemical biology probes, receptor-binding motif optimization, and synthetic intermediates feeding into larger functional molecules.

3. Protected Amino Acid Chemistry

Fmoc-O-tert.butyl-L-threonine is suitable for protected amino acid synthesis workflows that require orthogonality between N-protection and side-chain protection. The Fmoc carbamate masks the amino group to control peptide coupling selectivity, while the tert-butyl ether on the hydroxyl enables selective deprotection without exposing the alcohol prematurely. The protected functional groups facilitate controlled conversion into peptide building blocks, protected fragments for sequential assembly, and chiral intermediates for further derivatization of the threonine side chain. The compound's protected architecture supports reproducible synthetic planning in fine chemical synthesis, where protecting-group compatibility and chemoselective unveiling of reactive sites are central to route design.

4. Bioconjugation Chemistry

Fmoc-O-tert.butyl-L-threonine is employed in bioconjugation-oriented synthesis where threonine hydroxyl functionality is leveraged as a defined attachment or modification point after deprotection. The Fmoc-protected amine and O-tert-butyl ether help maintain stability during preparation of peptide-based linkers, affinity handles, or biomolecule-binding fragments that incorporate threonine residues. Following tert-butyl deprotection, the exposed β-hydroxyl can be converted into conjugation-ready motifs such as linker esters, carbonate linkages, or hydroxyl-reactive handles compatible with biomolecule coupling chemistries. The stereodefined threonine residue supports consistent spatial presentation in conjugates used for chemical biology research, analytical standards, and biomolecular labeling workflows.

5. Pharmaceutical Manufacturing

Fmoc-O-tert.butyl-L-threonine is relevant to pharmaceutical manufacturing and process chemistry as a protected amino acid building block for producing threonine-containing peptides and peptide intermediates under scalable synthetic conditions. The orthogonal protecting-group set supports reliable N-terminal deprotection and side-chain hydroxyl masking during manufacturing stages that require controlled chemoselectivity and minimized byproduct formation. The threonine β-hydroxyl, once unveiled, can serve as a functional site for downstream derivatization steps that tailor solubility, stability, or conjugation properties of peptide intermediates. The compound's role as a chiral, protected intermediate aligns with industrial fine chemical production where reproducible peptide coupling sequences and predictable deprotection behavior are required for consistent product generation.

1. Low bone turnover and low BMD in Down syndrome: effect of intermittent PTH treatment

2. Cationic cell-penetrating peptides are potent furin inhibitors

3. Sex differences in oxidative stress level and antioxidative enzymes expression and activity in obese pre-diabetic elderly rats treated with metformin or liraglutide

4. P-selectin and Complement’s Role in a Neonatal Model of Germinal Matrix Hemorrhage-Induced Secondary Injury

5. Quantitative Analysis of Ligands Effects on Bioefficacy of Nanoemulsion encapsulating Depigmenting Active